Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Nov 28, 2022

Keywords

ClinConnect Summary

This clinical trial is studying patients with atrial fibrillation, which is a type of irregular heartbeat. The researchers want to understand what factors might cause atrial fibrillation to come back after a treatment called catheter ablation, a procedure that helps restore a normal heart rhythm. By collecting information from patients who have undergone this treatment at Peking University Third Hospital, they aim to identify risks and improve how doctors manage patients with this condition.

To participate in this study, you need to be over 18 years old and have been diagnosed with atrial fibrillation through an electrocardiogram (a test that checks your heart's rhythm). Unfortunately, if you have certain health issues like severe blood disorders, cancer, or conditions that significantly affect your mobility or mental state, you may not be eligible. If you join the study, you can expect regular check-ups and follow-ups to monitor your heart health and gather important information about your recovery. Your participation could help improve treatment and care for others with atrial fibrillation in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1) Age \> 18
• • 2) ECG or holter electrocardiogram confirmed atrial fibrillation
• Exclusion Criteria:
• • 1) Hematological diseases, autoimmune diseases and malignant tumors
• • 2) Immobility caused by hemiplegia or severe trauma
• • 3) The expected survival time is less than 2 years
• • 4) Poor compliance and high risk of expected loss of follow-up
• • 5) Disorders of consciousness or Alzheimer's disease